Sun Pharmaceutical Industries Ltd. is talking with advisers about a possible bid for New York-listed wellness company Organon & Co., according to people familiar with the matter.India’s biggest pharmaceutical company, with a market capitalisation of $43 billion, has held preliminary discussions with global lenders to arrange financing for a possible deal, the people said, asking not to be identified because the information is private. Considerations are preliminary and Sun Pharma may decide to not pursue a ...